Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01422239 · ClinicalTrials.gov registry record · Phase 1
A Smoking Cessation Treatment for Adult Women
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT01422239 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 28 participants.
The verdict
NCT01422239, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and pilot test a smoking cessation counseling that focuses on the perceived risks of quitting smoking (e.g., weight gain, managing cravings and negative affect, loss of enjoyment). Aim 1: To develop the risk-based smoking cessation intervention. Aim 2: To examine whether manualized smoking cessation counseling about the perceived risks of quitting is feasible to administer and acceptable to adult women who want to quit smoking. Aim 3: To examine smoking cessation outcomes for women who receive the risk-based treatment in comparison to standard smoking counseling. It is expected that women who receive risk-based counseling will show better quit rates and a longer time to relapse than women who receive standard treatment.
Interventions
- BEHAVIORAL Standard Treatment
- BEHAVIORAL Tailored treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01422239
The ClinicalTrials.gov registry entry for NCT01422239 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Treatment is the first listed.
NCT01422239 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01422239 about?
NCT01422239 is a clinical study titled "A Smoking Cessation Treatment for Adult Women". The purpose of this study is to develop and pilot test a smoking cessation counseling that focuses on the perceived risks of quitting smoking (e.g., weight gain, managing cravings and negative affect, loss of enjoyment). Aim 1: To develop the risk-based smoking cessation intervention. Aim 2: To ex...
What is the current status of trial NCT01422239?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2011-01. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01422239?
The interventions under investigation include: Standard Treatment (BEHAVIORAL), Tailored treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01422239?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.